Drug
Pacritinib
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Splenomegaly | 105 | 64.0 | 66.3 | signal |
| 2 | Transfusion | 84 | 57.0 | 58.6 | signal |
| 3 | Platelet Count Increased | 61 | 33.2 | 33.9 | signal |
| 4 | Full Blood Count Abnormal | 35 | 23.6 | 23.8 | signal |
| 5 | Platelet Count Decreased | 290 | 19.3 | 21.3 | signal |
| 6 | Hospice Care | 26 | 18.7 | 18.9 | signal |
| 7 | Haemoglobin Decreased | 206 | 14.2 | 15.2 | signal |
| 8 | Full Blood Count Decreased | 38 | 13.4 | 13.5 | signal |
| 9 | Red Blood Cell Count Decreased | 50 | 12.4 | 12.6 | signal |
| 10 | Laboratory Test Abnormal | 42 | 10.1 | 10.2 | signal |
| 11 | Intentional Dose Omission | 35 | 9.1 | 9.2 | signal |
| 12 | Gout | 22 | 8.7 | 8.7 | signal |
| 13 | Loss Of Personal Independence In Daily Activities | 57 | 8.5 | 8.6 | signal |
| 14 | Blood Iron Decreased | 14 | 8.4 | 8.4 | signal |
| 15 | Brain Fog | 17 | 8.3 | 8.3 | signal |
| 16 | White Blood Cell Count Increased | 44 | 8.1 | 8.2 | signal |
| 17 | Product Dose Omission Issue | 323 | 8.0 | 8.9 | signal |
| 18 | Leukaemia | 10 | 7.5 | 7.5 | signal |
| 19 | Night Sweats | 33 | 7.3 | 7.3 | signal |
| 20 | Diarrhoea | 622 | 6.8 | 8.4 | signal |
| 21 | Petechiae | 10 | 6.8 | 6.8 | signal |
| 22 | Taste Disorder | 19 | 6.7 | 6.7 | signal |
| 23 | Therapy Change | 9 | 6.6 | 6.6 | signal |
| 24 | Intentional Product Misuse | 80 | 6.5 | 6.7 | signal |
| 25 | Product Dose Omission In Error | 24 | 6.3 | 6.4 | signal |
| 26 | Decreased Activity | 9 | 5.9 | 6.0 | signal |
| 27 | Ageusia | 18 | 5.1 | 5.1 | signal |
| 28 | Blood Test Abnormal | 10 | 5.0 | 5.1 | signal |
| 29 | Off Label Use | 602 | 4.9 | 5.9 | signal |
| 30 | Cytopenia | 8 | 4.7 | 4.7 | signal |
| 31 | Epistaxis | 48 | 4.5 | 4.6 | signal |
| 32 | Post Procedural Haemorrhage | 7 | 4.2 | 4.3 | signal |
| 33 | Emotional Disorder | 18 | 4.1 | 4.1 | signal |
| 34 | Illness | 57 | 4.0 | 4.1 | signal |
| 35 | Contusion | 51 | 3.8 | 3.8 | signal |
| 36 | Internal Haemorrhage | 6 | 3.7 | 3.7 | signal |
| 37 | Peripheral Swelling | 79 | 3.6 | 3.7 | signal |
| 38 | Fatigue | 381 | 3.5 | 3.8 | signal |
| 39 | Product Use Complaint | 7 | 3.2 | 3.2 | signal |
| 40 | Bone Pain | 26 | 3.1 | 3.2 | signal |
| 41 | Disease Progression | 51 | 3.1 | 3.1 | signal |
| 42 | Haemorrhage | 44 | 3.0 | 3.0 | signal |
| 43 | White Blood Cell Count Decreased | 45 | 2.9 | 3.0 | signal |
| 44 | Fluid Retention | 21 | 2.9 | 2.9 | signal |
| 45 | Insurance Issue | 6 | 2.9 | 2.9 | signal |
| 46 | Dysgeusia | 29 | 2.7 | 2.8 | signal |
| 47 | Sars-cov-2 Test Positive | 5 | 2.6 | 2.7 | no signal |
| 48 | Drug Effect Less Than Expected | 5 | 2.5 | 2.5 | no signal |
| 49 | Death | 303 | 2.5 | 2.7 | signal |
| 50 | Product Complaint | 3 | 0.9 | 0.9 | no signal |